title: The authors reply.
authors.affiliation: MediCity Research Laboratory, University of Turku, Turku, Finland, and Department of Medical Microbiology and Immunology, University of Turku, Turku, Finland; Department of Surgery, Helsinki University Central Hospital, Helsinki, Finland; MediCity Research Laboratory, University of Turku, Turku, Finland, and Department of Medical Microbiology and Immunology, University of Turku, Turku, Finland; Department of Bacteriology and Immunology, University of Helsinki, Finland; MediCity Research Laboratory, University of Turku, Turku, Finland, and Department of Medical Microbiology and Immunology, University of Turku, Turku, Finland.
authors.forename: Mikael
authors.initials: M
authors.lastname: Maksimow
authors.forename: Lea
authors.initials: L
authors.lastname: Kyhälä
authors.forename: Leena
authors.initials: L
authors.lastname: Kylänpää
authors.forename: Panu
authors.initials: P
authors.lastname: Mentula
authors.forename: Gennady G
authors.initials: GG
authors.lastname: Yegutkin
authors.forename: Heikki
authors.initials: H
authors.lastname: Repo
authors.forename: Marko
authors.initials: M
authors.lastname: Salmi
mesh_terms: D015720:5'-Nucleotidase / Q000097:blood*; D006801:Humans; D009102:Multiple Organ Failure / Q000209:etiology* / Q000503:physiopathology*; D010195:Pancreatitis / Q000150:complications* / Q000503:physiopathology*
chemical_list: D015720:5'-Nucleotidase